162 related articles for article (PubMed ID: 23494611)
1. Clinical features and treatment outcome of borderline resectable pancreatic head/body cancer: a multi-institutional survey by the Japanese Society of Pancreatic Surgery.
Kato H; Usui M; Isaji S; Nagakawa T; Wada K; Unno M; Nakao A; Miyakawa S; Ohta T
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):601-10. PubMed ID: 23494611
[TBL] [Abstract][Full Text] [Related]
2. Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
Takahashi S; Kinoshita T; Konishi M; Gotohda N; Kato Y; Kinoshita T; Kobayashi T; Mitsunaga S; Nakachi K; Ikeda M
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):567-74. PubMed ID: 21331805
[TBL] [Abstract][Full Text] [Related]
3. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society.
Yamada S; Fujii T; Takami H; Hayashi M; Iwata N; Kanda M; Tanaka C; Sugimoto H; Nakayama G; Koike M; Fujiwara M; Kodera Y
Surgery; 2017 Oct; 162(4):784-791. PubMed ID: 28655416
[TBL] [Abstract][Full Text] [Related]
5. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Satoi S; Yamaue H; Kato K; Takahashi S; Hirono S; Takeda S; Eguchi H; Sho M; Wada K; Shinchi H; Kwon AH; Hirano S; Kinoshita T; Nakao A; Nagano H; Nakajima Y; Sano K; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):590-600. PubMed ID: 23660962
[TBL] [Abstract][Full Text] [Related]
6. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
7. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.
Murakami Y; Satoi S; Motoi F; Sho M; Kawai M; Matsumoto I; Honda G;
Br J Surg; 2015 Jun; 102(7):837-46. PubMed ID: 25877050
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma.
Glazer ES; Rashid OM; Klapman JB; Harris CL; Hodul PJ; Pimiento JM; Malafa MP
Pancreatology; 2017; 17(1):130-134. PubMed ID: 28043760
[TBL] [Abstract][Full Text] [Related]
9. Treatment Strategy for Borderline Resectable Pancreatic Cancer With Radiographic Artery Involvement.
Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
Pancreas; 2016 Nov; 45(10):1438-1446. PubMed ID: 27088490
[TBL] [Abstract][Full Text] [Related]
10. Significance of neoadjuvant therapy for borderline resectable pancreatic cancer: a multicenter retrospective study.
Kurahara H; Shinchi H; Ohtsuka T; Miyasaka Y; Matsunaga T; Noshiro H; Adachi T; Eguchi S; Imamura N; Nanashima A; Sakamoto K; Nagano H; Ohta M; Inomata M; Chikamoto A; Baba H; Watanabe Y; Nishihara K; Yasunaga M; Okuda K; Natsugoe S; Nakamura M
Langenbecks Arch Surg; 2019 Mar; 404(2):167-174. PubMed ID: 30649607
[TBL] [Abstract][Full Text] [Related]
11. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.
Wang G; Zhou D
Ultrason Sonochem; 2015 Nov; 27():694-702. PubMed ID: 26113389
[TBL] [Abstract][Full Text] [Related]
12. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
13. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
14. Aggressive surgery for borderline resectable pancreatic cancer: evaluation of National Comprehensive Cancer Network guidelines.
Yamada S; Fujii T; Sugimoto H; Nomoto S; Takeda S; Kodera Y; Nakao A
Pancreas; 2013 Aug; 42(6):1004-10. PubMed ID: 23532000
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
[TBL] [Abstract][Full Text] [Related]
17. Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries.
Miura JT; Evans DB; Pappas SG; Gamblin TC; Turaga KK
Ann Surg Oncol; 2013 Dec; 20(13):4338-47. PubMed ID: 24002538
[TBL] [Abstract][Full Text] [Related]
18. Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Motoi F; Unno M; Takahashi H; Okada T; Wada K; Sho M; Nagano H; Matsumoto I; Satoi S; Murakami Y; Kishiwada M; Honda G; Kinoshita H; Baba H; Hishinuma S; Kitago M; Tajima H; Shinchi H; Takamori H; Kosuge T; Yamaue H; Takada T
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):148-58. PubMed ID: 23913634
[TBL] [Abstract][Full Text] [Related]
19. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study.
Miura T; Hirano S; Nakamura T; Tanaka E; Shichinohe T; Tsuchikawa T; Kato K; Matsumoto J; Kondo S
Surgery; 2014 Mar; 155(3):457-67. PubMed ID: 24462074
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated.
Chuong MD; Springett GM; Freilich JM; Park CK; Weber JM; Mellon EA; Hodul PJ; Malafa MP; Meredith KL; Hoffe SE; Shridhar R
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):516-22. PubMed ID: 23562768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
